The Management of Hematopoietic Stem Cell Transplant in People with HIV

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2024 Oct 26

PMID 39459894

Authors

Jana K Dickter

Courtney Moc Willeford

Affiliations

Soon will be listed here.

Abstract

Hematopoietic stem cell transplant (HSCT) is now recognized as a standard treatment option for people with HIV (PWH) who develop high-risk hematologic malignancies. However, the involved polypharmacy can lead to complications from drug interactions and toxicities, affecting the efficacy and safety of chemotherapy and antiretroviral therapy (ART). Managing these patients requires a personalized approach, including the careful selection of ART based on previous therapies and potential interactions, alongside risk assessment for infections. This discussion will address the history of HSCT in PWH and management considerations for this group.

References

Taplitz R, Kennedy E, Flowers C . Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary. J Oncol Pract. 2018; 14(11):692-695. DOI: 10.1200/JOP.18.00366. View

Navarro J, Ribera J, Oriol A, Romeu J, Sirera G, Mate J . Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma. Leuk Lymphoma. 2003; 43(9):1837-42. DOI: 10.1080/1042819021000006402. View

Chan J, Lau S, Yuen K, Woo P . Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect. 2016; 5:e19. PMC: 4820671. DOI: 10.1038/emi.2016.18. View

Franceschi S, Lise M, Clifford G, Rickenbach M, Levi F, Maspoli M . Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010; 103(3):416-22. PMC: 2920013. DOI: 10.1038/sj.bjc.6605756. View

McDonald L, Gerding D, Johnson S, Bakken J, Carroll K, Coffin S . Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66(7):e1-e48. PMC: 6018983. DOI: 10.1093/cid/cix1085. View

Patel P, Hanson D, Sullivan P, Novak R, Moorman A, Tong T . Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148(10):728-36. DOI: 10.7326/0003-4819-148-10-200805200-00005. View

Schijvens A, Ter Heine R, de Wildt S, Schreuder M . Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol. 2018; 34(3):389-403. PMC: 6349812. DOI: 10.1007/s00467-018-3929-z. View

Shiels M, Pfeiffer R, Gail M, Hall H, Li J, Chaturvedi A . Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011; 103(9):753-62. PMC: 3086877. DOI: 10.1093/jnci/djr076. View

Kompa K, Trottier C, Hyman C, Kohli R . Disseminated Complex Myositis in a Patient With Graft-Versus-Host Disease. Open Forum Infect Dis. 2022; 9(8):ofac385. PMC: 9387913. DOI: 10.1093/ofid/ofac385. View

10.

Lederman M, Penn-Nicholson A, Cho M, Mosier D . Biology of CCR5 and its role in HIV infection and treatment. JAMA. 2006; 296(7):815-26. DOI: 10.1001/jama.296.7.815. View

11.

Navarro J, Ribera J, Oriol A, Vaquero M, Romeu J, Batlle M . Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Br J Haematol. 2001; 112(4):909-15. DOI: 10.1046/j.1365-2141.2001.02656.x. View

12.

Kagawa K, Fujino H, Miki H, Sogabe K, Takahashi M, Maruhashi T . Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of Cryptosporidium oocysts by intestinal biopsies. Transpl Infect Dis. 2017; 20(2):e12826. DOI: 10.1111/tid.12826. View

13.

Carbone A, Vaccher E, Gloghini A . Hematologic cancers in individuals infected by HIV. Blood. 2021; 139(7):995-1012. DOI: 10.1182/blood.2020005469. View

14.

Yarchoan R, Uldrick T . HIV-Associated Cancers and Related Diseases. N Engl J Med. 2018; 378(11):1029-1041. PMC: 6890231. DOI: 10.1056/NEJMra1615896. View

15.

Doucette K, Fishman J . Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis. 2004; 38(10):1428-39. DOI: 10.1086/420746. View

16.

Trepanier D, Freitag D, Yatscoff R . Pharmacokinetics and metabolism of sirolimus. Ther Drug Monit. 2000; 22(1):31-5. DOI: 10.1097/00007691-200002000-00006. View

17.

. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ. 1982; 60(4):555-64. PMC: 2536088. View

18.

Turner N, Strand A, Grewal D, Cox G, Arif S, Baker A . Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis. Antimicrob Agents Chemother. 2019; 63(3). PMC: 6395918. DOI: 10.1128/AAC.02337-18. View

19.

Bullingham R, Nicholls A, Kamm B . Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998; 34(6):429-55. DOI: 10.2165/00003088-199834060-00002. View

20.

Sebastian E, Martin J, McDonald G, Flores T, Rodriguez A, Blanco A . Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant. 2010; 46(4):612-4. DOI: 10.1038/bmt.2010.156. View